Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation

Article

Abstract: Introduction: secondary hyperparathyroidism (SHP) is frequent in patients with chronic kidney diseas

Palabras claves:

calcimimetics, Chronic kidney disease, inflammation, vitamin D analogs

Autores:

Checa-Ros A., Dapena F., D’marco L., Gamero D., Nava M., Salazar J., Soto C., Valmore Bermúdez

Fuentes:

scopus